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Abstract Tyrosine phosphorylation of multiple proteins, includ-
ing the receptor itself, is an initial event in IL-2 signaling and
leads to recruitment of SH2 or PTB domain-containing proteins
to the receptor. In this study, we have used subdomains of the
IL-2 receptor L chain (IL-2RL) expressed in Escherichia coli as
GST fusion proteins to identify the tyrosine residues that could
be phosphorylated by p56lck, one of the critical tyrosine kinases
activated by IL-2. We report that recombinant p56lck phospho-
rylates in vitro tyrosine residues within the IL-2RL chain but not
those within the IL-2RQ chain. p56lck phosphorylates tyrosine
residues 355, 358 and 361 but not 338 of the IL-2RL chain acidic
subdomain. Interestingly, phosphorylation of Tyr-358 appears to
require the presence of either Tyr-355 or Tyr-361. p56lck also
phosphorylates very efficiently the two tyrosines present in the
IL-2RL chain C-terminal region, Tyr-392 and Tyr-510. We also
investigated the association of p56lck with the IL-2RL chain
which was found to depend on a short stretch of the IL-2RL chain
acidic subdomain, and to be independent of the presence of its
tyrosine residues.
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1. Introduction
Recent studies have uncovered the complexity of the signal-
ing events induced by interleukin-2 (IL-2), a cytokine that
plays a central role in lymphocyte di¡erentiation, proliferation
and apoptosis [1,2]. The IL-2 receptor (IL-2R) comprises three
polypeptide subunits, the K, L and Q chains, of which only L
and Q are critical for signal transduction. IL-2RL deletion
analyses have delineated three functional cytoplasmic subdo-
mains, respectively named proximal (or serine-rich), acidic
and C-terminal [3], that cooperate for a full proliferative re-
sponse to IL-2 [4^7]. IL-2 binding induces oligomerization of
its receptor, which results in activation of several protein ty-
rosine kinases (PTK): p56lck of the src family [8], the PTK
Syk of the Syk/Zap 70 family [9], and JAK1 and JAK3 of the
Janus kinase family [10]. These kinases phosphorylate multi-
ple cellular substrates [11^14] including the IL-2R L and Q
chains themselves [15,16]. Phosphorylated tyrosine residues
in the IL-2R complex serve as docking sites for signaling or
adaptor proteins that contain Src homology 2 (SH2) or phos-
photyrosine binding (PTB) domains.
The ¢rst non-receptor PTK found in association with the
IL-2R was p56lck [17]. p56lck is expressed predominantly in T
lymphocytes and plays an essential role in T lymphocyte ma-
turation and proliferation. p56lck has been reported to asso-
ciate constitutively with the IL-2RL chain, and IL-2 stimula-
tion increases its kinase activity [18,19]. Based on experiments
using IL-2RL deletion mutants transfected into COS cells, it
was observed that this interaction involves the catalytic do-
main of p56lck and the IL-2RL acidic region and that p56lck
may phosphorylate several tyrosine residues of the IL-2RL
chain [17]. However, direct biochemical evidence for this in-
teraction or identi¢cation of p56lck target tyrosine residues in
the IL-2RL chain are still missing.
In this work, we have used IL-2RL subdomain GST fusion
proteins and recombinant p56lck to directly identify the tyro-
sine residues that can be phosphorylated by p56lck. The inter-
actions between the cytoplasmic subdomains of IL-2RL and
p56lck have been studied and we provide biochemical evidence
for p56lck association with a short stretch of the IL-2RL chain
acidic subdomain.
2. Materials and methods
2.1. Construction of GST fusion proteins
A plasmid, pDKCRL, containing the full length cDNA for human
IL-2RL chain was kindly provided by Dr. T. Kono [20]. A BclI-BalI
fragment was inserted into BamHI-SmaI-digested PGEX-3X plasmid
(Pharmacia) to yield a GST fusion protein containing the full length
IL-2RL chain cytoplasmic domain (GST-LFL, amino acids 240^525).
This plasmid was then used as a template to amplify cDNA fragments
by PCR and construct PGEX plasmids encoding the following GST
fusion IL-2RL chain subdomains: GST-LProx (amino acids 240^307),
GST-LAci (amino acids 306^383) and GST-LCter (amino acids 382^
525). In addition, for the purpose of some of the experiments de-
scribed in this report, the GST-LAci protein was further expressed
as three shorter constructs GST-LAci1, GST-LAci2 and GST-LAci3
corresponding to amino acids 306^337, 335^365 and 362^383 respec-
tively. For numbering amino acids of the IL-2RL chain as shown
here, the initial methionine residue of the precursor polypeptide is
taken as number 1. Mutations of tyrosine residues into phenylalanine
were achieved by PCR using appropriate oligonucleotides containing
a TAC to TTC codon change. For GST-IL-2RQ construction, a frag-
ment of the IL-2RQ cDNA, corresponding to the intracytoplasmic
domain (amino acids 288^369), was ampli¢ed by RT-PCR from pe-
ripheral blood lymphocytes mRNA (sense primer: 5P-GAA CGG
ACG ATG CCC C; antisense primer: 5P-GTT CAG GTT TCA
GGC) and inserted into PGEX-2T using the IL-2RQ cDNA endoge-
nous EcoRI site. All constructs, whether wild type or mutated, were
veri¢ed by DNA sequencing. GST fusion proteins were produced in
Escherichia coli strain BL21(DE3) by induction for 4 h with 1 mM
IPTG and puri¢ed by adsorption onto glutathione (GSH)-Sepharose
beads as previously described [21].
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2.2. Baculovirus-expressed p56lck and in vitro phosphorylation
The cDNA for human p56lck was inserted in AcNMPV and the
selected recombinant baculovirus was used to infect Sf9 insect cells.
48 h after infection, Sf9 cells were harvested, washed once with PBS
and lysed. The cell lysate was centrifuged at 100 000Ug for 30 min,
the supernatant was recovered, supplemented with 10% glycerol and
stored at 380‡C. p56lck represented up to 1% of the total proteins in
the crude Sf9 cell lysate as judged by scanning densitometry of Coo-
massie blue-stained SDS-polyacrylamide gel.
To study phosphorylation of GST-IL-2RL by p56lck, 100 pmol of
puri¢ed GST fusion proteins was adsorbed onto GSH-Sepharose
beads and washed in kinase reaction bu¡er (20 mM HEPES pH
7.5, 10 mM MnCl2, 1.5 WM ATP). Recombinant p56lck-containing
Sf9 cell lysate (0.7 Wl) was then added in a ¢nal volume of 30 Wl
kinase bu¡er supplemented with 10 WCi [Q-32P]ATP. After 15 min at
30‡C the reaction was stopped by adding 1 ml of cold lysis bu¡er, and
following four washes the proteins bound to the beads were recovered
by boiling in Laemmli sample bu¡er and separated by SDS-PAGE.
Gels were treated by bathing in 1 M KOH for 1 h at 55‡C, stained
with Coomassie brilliant blue and dried before autoradiography.
2.3. Cell culture
The human T-cell chronic lymphocytic leukemia-derived, IL-2-de-
pendent Kit 225 cell line was kindly provided by Dr. T. Hori (Kyoto
University, Japan) [22]. Cells were maintained in culture medium
(RPMI 1640, 10% fetal calf serum and antibiotics) supplemented
with 0.5 nM recombinant human IL-2 (generously provided by P.
Ferrara, Sano¢, France). Kit 225 cells were deprived of IL-2 by wash-
ing three times and resuspending the cells at 5U105/ml in culture
medium without IL-2 for 48 h. For stimulation, IL-2-deprived Kit
225 cells were resuspended at 2U107/ml in culture medium and in-
cubated at 37‡C without (control) or with 1 nM recombinant IL-2 for
5 min. Cells were harvested by centrifugation and incubated for 30 min
on ice in cold lysis bu¡er (50 mM Tris pH 8, 150 mM NaCl, 0.5%
NonidetP40, 10 mM NaF, 1 mM EDTA, 1 mM PMSF, 1 mM vana-
date and 2 Wg/ml each leupeptin and aprotinin). Lysates were clari¢ed
by centrifugation at 15 000Ug for 20 min at 4‡C.
2.4. GST pull down and kinase assay
To study phosphorylation mediated by kinases present in Kit 225
cells, IL-2-stimulated cell lysates (5 mg proteins) were precleared with
GSH-Sepharose beads. Precleared lysates were rocked for 2 h at 4‡C
with 50 Wg of puri¢ed GST fusion proteins adsorbed onto GSH-
Sepharose beads. The beads were then washed in kinase bu¡er and
incubated for 15 min at 30‡C in kinase bu¡er supplemented with
10 WCi [Q-32P]ATP. The reaction was stopped by boiling in sample
bu¡er, and proteins were separated and analyzed as above.
2.5. Antibodies and immunoblotting
Polyclonal antibodies against IL-2RL and p56lck proteins were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The
anti-GST monoclonal antibody was raised and puri¢ed in the labo-
ratory.
For immunoblotting the membranes were blocked for 2 h at room
temperature with 5% non-fat dry milk in Tris-bu¡ered saline (TBS),
0.2% Tween (TBS-T). Membranes were washed four times in TBS-T
and incubated for 1 h with optimal concentrations of primary anti-
bodies diluted in TBS-0.05% Tween. Following four additional washes
in TBS-T, the membranes were further incubated for 45 min with
horseradish peroxidase-conjugated secondary antibodies (sheep anti-
mouse Ig from Amersham). The bands were revealed using Amersham
ECL reagents and autoradiographic ¢lms.
3. Results
3.1. Expression of IL-2R and subdomains as GST-fusion
proteins in E. coli
The full length IL-2RL (LFL, amino acids 240^525) and Q
(amino acids 288^369) cytoplasmic regions as well as IL-2RL
proximal (LProx, amino acids 240^307), acidic (LAci, amino
acids 306^383) and C-terminal (LCter, amino acids 382^525)
subdomains were expressed as GST fusion proteins in E. coli
(Fig. 1). These proteins could be expressed and puri¢ed in
soluble form at reasonable levels, although, as shown in
Fig. 1B, some level of degradation could not be avoided,
particularly in the full length protein. In contrast, the acidic
as well as the C-terminal subdomains could be routinely pu-
ri¢ed as single intact proteins. In addition, the full length
GST-IL-2RL as well as the GST-LCter proteins were recog-
nized in Western blot by two di¡erent antibodies raised
against a C-terminal IL-2RL peptide (not shown).
3.2. In vitro phosphorylation of the IL-2RL chain by p56lck
Although transient expression of p56lck together with the
IL-2RL chain in COS cells [17] clearly indicated that p56lck
was involved in the phosphorylation of the IL-2RL chain, no
detailed study of the p56lck target tyrosine residues in the
IL-2RL chain has been reported. We have used the GST fu-
sion proteins described above to determine which residues
were phosphorylated in vitro by baculovirus-expressed
p56lck. As shown in Fig. 2A, p56lck phosphorylated the full
GST-IL-2RL as well as the acidic and C-terminal subdomains
but neither the Prox subdomain nor the control GST protein.
In addition, a similar GST-IL-2RQ cytoplasmic domain con-
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Fig. 1. Expression of GST-IL2R fusion proteins. A: Schematic rep-
resentation of the IL-2R cytoplasmic subdomains and PGEX con-
structs encoding GST-LFL (amino acids 240^525), GST-LProx (ami-
no acids 240^307), GST-LAci (amino acids 306^383), GST-LCter
(amino acids 382^525) and GST-Q (amino acids 288^369). B: 100 ng
of GST-IL-2R fusion proteins were puri¢ed on GSH-Sepharose
beads, separated by SDS-PAGE on a 10% acrylamide gel, trans-
ferred onto a nitrocellulose membrane and analyzed by Western
blot with anti-GST antibodies. The apparent molecular mass of
each GST-fusion protein is indicated.
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struct, although containing four tyrosine residues, was not
phosphorylated by p56lck.
To identify the tyrosine residues which were phosphorylated
by p56lck, we generated IL-2RL GST fusion proteins in which
each tyrosine residue was replaced by phenylalanine, individ-
ually or together as described in Section 2. A GST-LCter
protein mutated on both Tyr-392 and Tyr-510 was not phos-
phorylated by p56lck (Fig. 2B). When Tyr-392 or Tyr-510 was
individually mutated to phenylalanine, both proteins were
phosphorylated to a somewhat reduced level as compared to
the wild type protein (Fig. 2B). Thus both Tyr-392 and Tyr-
510 are e⁄ciently phosphorylated by p56lck in vitro.
Similar experiments were then undertaken with the acidic
domain that contains four tyrosine residues at positions 338,
355, 358 and 361. For the purpose of these experiments, a
shorter GST-LAci2 protein encoding residues 335^365 was
constructed. It was then used to generate mutants in which
a single Tyr, or all four Tyr were replaced by Phe. In addition,
each tyrosine residue was individually reintroduced in the 4F
construct. As shown in Fig. 3A, the GST-LAci2 construct was
heavily phosphorylated, and mutation of all four tyrosines
into phenylalanines (34F, lane 8) reduced its phosphorylation
to near background level. Analysis of the results of phospho-
rylation of the mutant proteins showed that replacing Tyr-338
by Phe did not reduce 32P incorporation, indicating that Tyr-
338 is probably not phosphorylated by p56lck (Fig. 3A, lane
4). Consistent with this hypothesis, the GST-LAci2 mutant
containing Tyr-338 alone was not phosphorylated by recombi-
nant p56lck (Fig. 3B, lane 1). In addition, replacement of ei-
ther Tyr-355, -358 or -361 by Phe reduced phosphorylation
signi¢cantly (Fig. 3A) and Tyr-355 as well as Tyr-361 were
found to behave as e⁄cient substrates when expressed alone,
whereas Tyr-358 was not phosphorylated (Fig. 3B). In these
experiments, equal loading in each lane was veri¢ed on the
Coomassie blue-stained gel (not shown).
3.3. p56lck association with GST-IL-2RL
The experiments described above showed that p56lck could
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Fig. 3. Analysis of the phosphorylation of the IL-2RL acidic subdo-
main by recombinant p56lck. Phosphorylation by p56lck was per-
formed as in Fig. 2, using the following GST fusion proteins as sub-
strate: (A) wild type GST-LAci, GST-LAci2 (amino acids 334^365),
GST-LAci2 proteins containing single Tyr to Phe mutations indi-
cated by their positions, and GST-LAci2 protein where all Tyr have
been mutated to Phe (34F), and (B) GST-L4F proteins in which
single tyrosine residues have been reintroduced at their original po-
sition. The autoradiograph shown here is from one representative
experiment out of three performed.
Fig. 4. Baculovirus-expressed recombinant p56lck associates with the
IL-2RL acidic subdomain. A: Puri¢ed GST fusion proteins (100
pmol) were pre-incubated for 1 h at 4‡C with 4 Wl of p56lck-contain-
ing Sf9 cell lysate and the beads were washed four times in lysis
bu¡er before the kinase reaction was allowed to proceed in the pres-
ence of [Q32P]ATP. Dotted circles indicate the position of GST and
GST-LProx proteins as veri¢ed on the Coomassie blue-stained gel.
B: The same experiment was performed with the shorter proteins
GST-LAci1, 2 and 3, the GST-LAci4F and the single Tyr to Phe
mutants of GST-LAci2 as indicated. Dotted circles indicate the posi-
tion of GST and GST-LAci1 and 3 proteins. Time of exposure for
this autoradiograph was 2 days.
Fig. 2. p56lck phosphorylates the acidic and C-terminal subdomains
of IL-2RL. A: Puri¢ed GST fusion proteins (100 pmol) were incu-
bated with p56lck-containing Sf9 cell lysates (0.7 Wl per point) in 30
Wl of kinase bu¡er supplemented with 10 WCi [Q32P]ATP, then sepa-
rated by SDS-PAGE. Following treatment with 1M KOH, the gel
was dried and autoradiographed. Dotted circles indicate the position
of GST, GST-LProx and GST-Q proteins as veri¢ed on the Coomas-
sie blue-stained gel. B: The same experiment as in A was performed
with GST-LCter proteins containing Tyr to Phe mutations at posi-
tion 392 (noted F/Y), 510 (Y/F) or both (F/F). For each mutation
two proteins obtained from independent E. coli colonies are shown.
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phosphorylate not only tyrosine residues present in the acidic
subdomain but also those in the C-terminal region. Further-
more, the presence of autophosphorylated p56lck, particularly
in Fig. 3, suggested that p56lck remained bound to the GST
fusion proteins. Indeed, previous reports have demonstrated
that p56lck associated with the acidic subdomain of the
IL-2RL chain [17,18]. It was therefore of interest to directly
address this question. For this purpose, in vitro phosphoryla-
tion experiments were performed under conditions slightly
di¡erent from above. Speci¢cally, recombinant baculovirus-
expressed p56lck was ¢rst incubated with the GST fusion pro-
teins adsorbed onto GSH-Sepharose beads. Following several
washes, the phosphorylation reaction was performed in the
presence of [Q-32P]ATP in kinase bu¡er. The rationale for
this procedure was that under these conditions the GST fusion
proteins could become phosphorylated by p56lck only if they
associated with p56lck during the preincubation step. Results
of a representative experiment in this series are shown in Fig.
4. The phosphorylation achieved under these conditions was
indeed much lower than in the previous experiments (Fig. 2A)
and ¢lms had to be exposed for a signi¢cantly longer period
of time to obtain signals of similar intensity. However, the
results clearly showed that the full length IL-2RL as well as
the GST-LAci fusion proteins were e⁄ciently phosphorylated
whereas phosphorylation of GST-LCter was barely detectable
(Fig. 4A). In addition, a faint band migrating at 56 kDa was
detectable in the GST-LAci lane which probably represents
associated p56lck that had undergone autophosphorylation.
This phosphorylated band could not be identi¢ed in associa-
tion with the full length IL-2RL due to the high signal inten-
sity generated by the 60 kDa GST-LFL itself, and was indeed
absent in the GST, GST-LProx and GST-LCter lanes. To
investigate the possible role of the tyrosine residues in this
association, the experiments were repeated using the shorter
GST-LAci subdomains as well as the Tyr to Phe mutants. The
following observations were made in this experiment (Fig.
4B): ¢rst, the short LAci2 protein (lane 4) as well as the single
Tyr to Phe mutants (lanes 6^9) were e⁄ciently phosphoryl-
ated under these conditions, indicating that residues other
than the tyrosines within this region (amino acids 335^365)
were involved in binding p56lck. This was con¢rmed by the
observation that the 4F mutant (lane 10), although not phos-
phorylated, was still able to bind p56lck, as seen by the pres-
ence of the 56 kDa autophosphorylated signal. Finally auto-
phosphorylated p56lck was not detectable in the presence of
either GST-LAci1 or GST-LAci3 (lanes 3 and 5).
To con¢rm that an endogenous p56lck could associate with
and phosphorylate GST-IL2RL proteins, cell lysates from IL-
2-stimulated Kit 225 cells were used. Cell lysates were incu-
bated with the various GST-IL-2RL proteins and the kinase
reaction was allowed to proceed after beads had been washed
in lysis bu¡er. As shown in Fig. 5, lysates from IL-2-stimu-
lated Kit 225 cells did indeed contain a tyrosine kinase activity
that was able to bind and phosphorylate the full length GST-
IL2RL and GST-LAci proteins, but not GST, GST-LCter or
GST-LProx (Fig. 5). Furthermore, a 56 kDa phosphorylated
band comigrating with p56lck in an anti-p56lck control immu-
noprecipitate from Kit 225 cell lysates was detectable in asso-
ciation with the GST-LAci protein.
Taken together, the results of the experiments described in
Figs. 4 and 5 provide direct biochemical evidence that p56lck
physically associates with the IL-2RL chain through its acidic
subdomain.
4. Discussion
An early and critical step in IL-2 signaling is the activation
of several tyrosine kinases and phosphorylation of the IL-2
receptor complex. It was found earlier that p56lck was one of
the important kinases activated by IL-2 stimulation. Experi-
ments using COS cells coexpressing p56lck and the IL-2RL
chain have demonstrated that p56lck associates with the acidic
domain of IL-2RL chain [17]. The data reported here are well
in agreement with these previous ¢ndings, and provide addi-
tional information. Indeed we have shown that GST-IL2RL
fusion proteins bound recombinant as well as natural p56lck.
This binding is direct, since it is observed in vitro with re-
combinant proteins, and the binding domain was assigned to
a short stretch of 30 amino acid residues of the IL-2RL chain
(amino acids 335^365). Furthermore, we showed that the as-
sociation of IL-2RL with p56lck does not require phosphoryl-
ation of the IL-2RL chain and that none of the four tyrosine
residues that are present in this subdomain appears to be
involved in the interaction with p56lck. These ¢ndings clearly
exclude a role of the SH2 domain of p56lck in its association
with the IL-2RL chain.
The IL-2RL acidic domain is su⁄cient for lck binding, but
lck activation requires the serine-rich (or proximal) domain
[23]. A large body of evidence indicates that the IL-2RL-
prox region is strictly required for IL-2-induced DNA syn-
thesis [4,8,24,25], but also for prevention of apoptosis [26].
Although necessary, the IL-2RL-prox region is not su⁄cient
for proliferation and additional events are required that de-
pend upon the presence of either the acidic or the C-terminal
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Fig. 5. p56lck from Kit 225 cell lysates associates with the IL-2RL
acidic subdomain. Puri¢ed GST fusion proteins were pre-incubated
with cell lysates (5 mg proteins) from IL-2-stimulated Kit 225 cells
for 2 h at 4‡C, and the beads were washed four times in lysis bu¡er
before the kinase reaction was allowed to proceed in the presence of
[Q32P]ATP. In the same experiment, p56lck was immunoprecipitated
(IP) from the Kit 225 cell lysate with anti-lck antibodies or preim-
mune serum (pi), and allowed to autophosphorylate under the same
conditions. All samples were run in parallel on a 10% polyacryl-
amide gel, which was then dried and autoradiographed.
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domain [4,6,7,27]. The IL-2RL acidic region seems to be re-
sponsible for a pathway leading to c-fos and c-jun induction
[28] whereas the C-terminal domain regulates STAT5 activa-
tion [4].
Transfection experiments using mutated or truncated IL-
2RL constructs clearly demonstrated that activation of the
Ras pathway, like activation of p56lck, required both the ser-
ine-rich and the acidic IL-2RL subdomains [28]. One of the
critical residues in the acidic subdomain is Tyr-338, which lies
within an NPQY environment representing a consensus bind-
ing site for the PTB domain of the Shc adaptor protein [7,25].
In parallel experiments (unpublished) we have indeed ob-
served that Shc associates with GST-LAci depending upon
phosphorylation of Tyr-338. However, our ¢nding that Tyr-
338 is not phosphorylated by p56lck suggests that the primary
role of p56lck in activation of the Ras pathway may rather be
the phosphorylation of Shc as recently demonstrated [29].
Since Tyr-338 phosphorylation is required for the recruitment
of Shc to the IL-2RL chain and the activation of the Ras
pathway, another kinase must be responsible for Tyr-338
phosphorylation. This kinase could be JAK-1 since it has
been reported that, when coexpressed in COS-7 cells with
IL-2RL chain constructs, JAK-1 was able to phosphorylate
Tyr-338 [7].
The acidic domain of the IL-2RL chain contains three addi-
tional tyrosine residues. Using GST-IL2RL fusion proteins
and a series of Tyr to Phe mutants, our data clearly demon-
strate that the three tyrosine residues Tyr-355, Tyr-358 and
Tyr-361 behaved as e⁄cient substrates in vitro for baculovi-
rus-expressed p56lck. However, the construct containing Tyr-
358 and Phe at all other relevant positions was not phos-
phorylated by p56lck. This result suggests that the presence
or the prior phosphorylation of one of these nearby Tyr res-
idues may in£uence the activity of p56lck towards Tyr-358.
Sequential phosphorylation of multiple residues has previ-
ously been described in other systems, particularly for ser-
ine/threonine or dual speci¢city kinases but little information
is available for src family tyrosine kinases. The precise roles of
residues Tyr-355, Tyr-358 and Tyr-361 are not yet elucidated.
Experiments using chimeric proteins suggest that they are not
critical for IL-2-induced cell proliferation [6,27]. Our data
show that p56lck can phosphorylate these residues but it is
not known whether these phosphorylated tyrosines serve as
a docking site for other signaling molecules, and in parallel
experiments, we have not identi¢ed additional proteins that
could associate with the phosphorylated IL-2RL acidic sub-
domain.
In vitro, p56lck phosphorylates very e⁄ciently Tyr-392 and
Tyr-510 in the C-terminal domain of the IL-2RL chain. These
two tyrosine residues of the IL-2RL are known to be involved
in the activation of STAT5, acting as docking sites for the
STAT5 SH2 domain [30,31]. In particular, phosphorylated
peptides derived from the IL-2L chain Tyr-392 or Tyr-510
have been reported to inhibit the DNA binding activity of
STAT5 [31]. In stable transfection experiments, it has also
been found that Tyr-392 alone could mediate STAT5 activa-
tion as well as Tyr-510 [4,32,33]. Thus, by phosphorylating the
IL-2RL chain STAT5 docking sites, p56lck may play an essen-
tial role in STAT5 activation by IL-2, and it has also been
recently established that p56lck is involved in STAT5 activa-
tion by the T-cell receptor [34].
We have shown here that p56lck phosphorylates ¢ve out of
the six tyrosine residues within the IL-2RL chain. It is of
interest to note that a strict respect of consensus src kinase
target sequences [35] is not observed for all these residues. In
particular Tyr-355 and -358 are not preceded by acidic resi-
dues, whereas an aspartate residue is indeed present at posi-
tion2 of Tyr-392 and of Tyr-510.
These results provide a better insight into the interactions
between p56lck and the IL-2RL chain. Experiments in progress
are using these GST-IL-2RL fusion proteins to study their
association with relevant signal transducing molecules acti-
vated by IL-2.
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